James Smith is an Infectious Disease physician. ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
685 Bryden Rd
Columbus, OH 432055004
Telephone
614-461-3214Registry record last updated 8 Jul 2007.
Clinical trials
- Retrovirus Epidemiology Donor Study I (REDS I)
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Takeda Pharmaceuticals U.S.A., Inc.Program year20243 payments
- Takeda Pharmaceuticals U.S.A., Inc.Program year20233 payments
- Hydrofera LLCProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
94.3%Cephalosporin Antibacterial14.8%Cefazolin Sodium37%Cefdinir31%Ceftriaxone26%Cefepime Hcl6%Part D<11 patientsPenicillins with extended spectrum14.1%Piperacillin-Tazobactam38%Amoxicillin32%Amoxicillin-Clavulanate Potass30%Part D≥84 patients+ 18 more classes in this area
Sensory organs
3.8%Fluoroquinolone Antibacterial3.8%Ciprofloxacin Hcl100%Part D≥53 patientsGenitourinary & hormones
0.8%Androgen0.8%Testosterone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Andrew Rambaut
University of Edinburgh
Olayinka Stephen Ilesanmi
University College Hospital
Maysaa El Sayed Zaki
Mansoura University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”